Cape Investment Advisory »

Candel Therapeutics shares owned by Cape Investment Advisory

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Cape Investment Advisory from 13F filings

Historical chart of Cape Investment Advisory investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Cape Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Cape Investment Advisory

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.7k 555 10.30

More positions owned by Cape Investment Advisory

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Blackrock Etf Trust Ii Isha Flex In Etf (BINC)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr 1 5yr Corp Bd (SCHJ)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Amazon (AMZN)
Apple (AAPL)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)

View all positions for Cape Investment Advisory

Top funds holding Candel Therapeutics

FMR
Rtw Investments
Acorn Capital Advisors
BlackRock
Saturn V Capital Management
Portolan Capital Management
Vanguard Capital Management
Vestal Point Capital
Millennium Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Heights Capital Management
Susquehanna International
Sands Capital Ventures

View all funds holding Candel Therapeutics